KIT and neoplasm: The management challenges are multifaceted, encompassing difficulties in precise bleeding site localization, constraints on endoscopic intervention options, limited efficacy of tyrosine kinase inhibitors (KIT inhibitors) in tumor downstaging, and complex intraoperative decision-making regarding resection of potential neoplastic foci.